Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications-Reference-Cited by-同舟云学术

Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

Published:2008-09 Issue:12 Volume:60 Page:1371-1382
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Miederer Matthias,Scheinberg David A.,McDevitt Michael R.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference65 articles.

1. Targeting of radio-isotopes for cancer therapy;Milenic;Cancer Biology & Therapy,2004

2. Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry;Nikula;Journal of Nuclear Medicine,1999

3. Cancer radioimmunotherapy with alpha-emitting nuclides;Couturier;European Journal of Nuclear Medicine and Molecular Imaging,2005

4. Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells;Friesen;Cancer Research,2007

5. Tumor therapy with targeted atomic nanogenerators;McDevitt;Science,2001

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. Nanoscale Metal–Organic Frameworks as a Photoluminescent Platform for Bioimaging and Biosensing Applications;Small;2024-07-16

3. Actinium-225 in Targeted Alpha Therapy;Journal of Medical Physics;2024-04

4. Alpha-Emitting Radionuclides: Current Status and Future Perspectives;Pharmaceuticals;2024-01-08

5. Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation;European Journal of Medical Research;2024-01-05